DOCMF (Dr. Martens) Net Change in Cash: $31 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DOCMF Dr. Martens PLC DOCMF
55 GF Score
Price $1.06
GF Value $0.97
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Dr. Martens Net Change in Cash?

Dr. Martens DOCMF +3.92% 55 Net Change in Cash is $31 Mil as of Mar. 2026. GuruFocus rates DOCMF with a GF Score™ of 55/100 and a GF Value™ of $0.97 (Fairly Valued). The stock has 3 warning signs investors should review.

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Dr. Martens's Net Change in Cash for the six months ended in Mar. 2026 was $113 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2026 was $31 Mil.

Dr. Martens Net Change in Cash Historical Data

* Premium members only.

The historical data trend for Dr. Martens's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr. Martens Net Change in Cash Chart

Dr. Martens Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only 150.72 -85.56 -58.96 57.88 32.53

Dr. Martens Semi-Annual Data
Mar18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.10 -21.43 78.81 -81.35 112.80
DOCMF
55GF Score
Dr. Martens PLC DOCMF
Net Change in Cash is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr. Martens Net Change in Cash Calculation

Dr. Martens's Net Change in Cash for the fiscal year that ended in Mar. 2026 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=190.267+-10.933+-143.733+-3.067
=33

Dr. Martens's Net Change in Cash for the quarter that ended in Mar. 2026

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=199.867+-5.2+-80.933+-0.933
=113

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Change in Cash →
What does a Net Change in Cash of $31 Mil mean?
Dr. Martens (DOCMF) has a Net Change in Cash of $31 Mil as of Mar. 2026. The net change in cash is the total change in cash and equivalents between the current period and the past period. View historical data for Dr. Martens and its competitors.
Is Dr. Martens' Net Change in Cash too high?
Dr. Martens' current Net Change in Cash is $31 Mil. Overall, Dr. Martens has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' Net Change in Cash compare to NKE and DECK?
Dr. Martens' Net Change in Cash of $31 Mil can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Change in Cash for a Manufacturing - Apparel & Accessories company?
A good Net Change in Cash depends on the Manufacturing - Apparel & Accessories industry context. However, Net Change in Cash should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Change in Cash mean?
A high Net Change in Cash can signal that a stock is expensive relative to its fundamentals. The net change in cash is the total change in cash and equivalents between the current period and the past period. View historical data for Dr. Martens and its competitors. Dr. Martens's current Net Change in Cash is $31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (DOCMF) is currently considered Fairly Valued. The stock's GF Value™ is $0.97, compared to a current price of $1.06 — trading 9.3% above its estimated fair value. The current Net Change in Cash is $31 Mil. Dr. Martens' overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Change in Cash calculated?
Net Change in Cash is calculated from a company's financial statements. For Dr. Martens (DOCMF), the current Net Change in Cash is $31 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr. Martens (DOCMF) Overvalued in 2026?

Based on GuruFocus' analysis, Dr. Martens stock appears to be overvalued. The current stock price of $1.06 is trading 9.3% above its estimated GF Value™ of $0.97. GuruFocus considers Dr. Martens to be Fairly Valued.

Key valuation signals for DOCMF:

  • Net Change in Cash: $31 Mil
  • GF Value™: $0.97 vs. price of $1.06 (9.3% above fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the DOCMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dr. Martens Business Description

Address 28 Jamestown Road, Camden, London, GBR, NW1 7BY
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
55GF Score

Get the complete analysis for DOCMF

Net Change in Cash is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.06
Price
$0.97
GF Value